State of Texas v. Pfizer — 5th Cir. (argued September 1, 2026)
The Fifth Circuit considers whether the Public Readiness and Emergency Preparedness Act, or PREP Act, shields Pfizer from Texas's consumer-protection suit accusing the company of misleading the public about its COVID-19 vaccine. The district court dismissed the suit on immunity, federal-preemption, and Texas-law pleading grounds. The judges also ask whether the challenged statements were closely enough connected to Pfizer's work under a federal vaccine contract to let Pfizer move the suit from state to federal court. Texas seeks reversal; Pfizer seeks affirmance.
State of Texas v. Pfizer (No. 25-10182) — U.S. Court of Appeals for the Fifth Circuit, argued September 1, 2026.
- 0:00Introduction
- 1:03Johnathan Stone — State of Texas
- 4:12The Federal Food, Drug, and Cosmetic Act
- 16:49Kannon K. Shanmugam — Pfizer